SUBSCRIBE
SUBSCRIBE

Corcept Therapeutics

NEWS
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
 · 
1 min read
Biotech 2005: New Drugs Hold The Key
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes
December 12, 2024
 · 
8 min read
Press Releases
Corcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS)
December 12, 2024
 · 
3 min read
Press Releases
Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing’s Syndrome and Provides Corporate Update
October 30, 2024
 · 
13 min read
Business
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
October 23, 2024
 · 
1 min read
Drug Development
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
June 3, 2024
 · 
3 min read
Drug Development
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
May 28, 2024
 · 
4 min read
Business
Corcept Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 1, 2024
 · 
10 min read
Drug Development
Corcept Completes Enrollment in Phase 4 CATALYST Trial
April 29, 2024
 · 
3 min read
Business
Corcept Therapeutics to Announce First Quarter 2024 Financial Results, Provide Corporate Update and Host Conference Call
April 24, 2024
 · 
1 min read
Drug Development
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
April 22, 2024
 · 
7 min read
Load More